Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0182 Transporter Info
Gene Name	SLC25A21
Transporter Name	Mitochondrial 2-oxodicarboxylate carrier
Gene ID	89874
UniProt ID	Q9BQT8

Post-Translational Modification of This DT
Overview of SLC25A21 Modification Sites with Functional and Structural Information
Sequence	M S A K P E V S L V R E A S R Q I V A G G S A G L V E I C L M H P L D V V K T R F Q I Q R C A T D P N S Y K S L V D S F R M I F Q M E G L F G F Y K G I L P P I L A E T P K R A V K F F T F E Q Y K K L L G Y V S L S P A L T F A I A G L G S G L T E A I V V N P F E V V K V G L Q A N R N T F A E Q P S T V G Y A R Q I I K K E G W G L Q G L N K G L T A T L G R H G V F N M V Y F G F Y Y N V K N M I P V N K D P I L E F W R K F G I G L L S G T I A S V I N I P F D V A K S R I Q G P Q P V P G E I K Y R T C F K T M A T V Y Q E E G I L A L Y K G L L P K I M R L G P G G A V M L L V Y E Y T Y S W L Q E N W
PTM type	X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A21 Cystine 29 has the potential to affect its expression or activity.
Phosphorylation
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	55
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A21 Serine 55 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A21			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	59
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A21 Serine 59 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A21 Threonine 84 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A21			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	173
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A21 Threonine 173 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A21			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A21 Threonine 175 has the potential to affect its expression or activity.
Ubiquitination
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[5]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	250
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A21 Cystine 250 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[5]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	214
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A21 Glycine 214 has the potential to affect its expression or activity.
Leucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[5]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	216
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A21 Leucine 216 has the potential to affect its expression or activity.
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A21			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	246
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A21 Lysine 246 has the potential to affect its expression or activity.

References
1	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
2	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
5	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence